Winograd B - Search Results

1

Preclinical phase II studies in human tumor lines: a European multicenter study.

Boven E, Winograd B, Fodstad O, Lobbezoo MW, Pinedo HM. Boven E, et al. Among authors: winograd b. Eur J Cancer Clin Oncol. 1988 Mar;24(3):567-73. doi: 10.1016/s0277-5379(98)90039-6. Eur J Cancer Clin Oncol. 1988. PMID: 3383962

2

Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study.

Boven E, Winograd B, Berger DP, Dumont MP, Braakhuis BJ, Fodstad O, Langdon S, Fiebig HH. Boven E, et al. Among authors: winograd b. Cancer Res. 1992 Nov 1;52(21):5940-7. Cancer Res. 1992. PMID: 1394220 Clinical Trial.

3

Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).

Winograd B, Boven E, Lobbezoo MW, Pinedo HM. Winograd B, et al. In Vivo. 1987 Jan-Feb;1(1):1-13. In Vivo. 1987. PMID: 2979758 Review.

4

The main steps in the development of anticancer agents.

Schwartsmann G, Winograd B, Pinedo HM. Schwartsmann G, et al. Among authors: winograd b. Radiother Oncol. 1988 Aug;12(4):301-13. doi: 10.1016/0167-8140(88)90020-5. Radiother Oncol. 1988. PMID: 3055073 Review.

5

Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter plates.

Pizao PE, Lyaruu DM, Peters GJ, van Ark-Otte J, Winograd B, Giaccone G, Pinedo HM. Pizao PE, et al. Among authors: winograd b. Br J Cancer. 1992 Oct;66(4):660-5. doi: 10.1038/bjc.1992.333. Br J Cancer. 1992. PMID: 1419603 Free PMC article.

6

In vitro chemosensitivity testing of multilayered microcultures.

Pizao PE, Winograd B, Peters GJ, Leyva A, Giaccone G, Pinedo HM. Pizao PE, et al. Among authors: winograd b. Anticancer Res. 1992 Jul-Aug;12(4):1319-22. Anticancer Res. 1992. PMID: 1503428

7

Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.

Keepers YP, Pizao PE, Peters GJ, van Ark-Otte J, Winograd B, Pinedo HM. Keepers YP, et al. Among authors: winograd b. Eur J Cancer. 1991;27(7):897-900. doi: 10.1016/0277-5379(91)90142-z. Eur J Cancer. 1991. PMID: 1834124

8

Comparative pharmacokinetics of cisplatin and three analogues in mice and humans.

van Hennik MB, van der Vijgh WJ, Klein I, Elferink F, Vermorken JB, Winograd B, Pinedo HM. van Hennik MB, et al. Among authors: winograd b. Cancer Res. 1987 Dec 1;47(23):6297-301. Cancer Res. 1987. PMID: 3315183

9

High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial.

Vermorken JB, ten Bokkel Huinink WW, Mandjes IA, Postma TJ, Huizing MT, Heimans JJ, Beijnen JH, Bierhorst F, Winograd B, Pinedo HM. Vermorken JB, et al. Among authors: winograd b. Semin Oncol. 1995 Aug;22(4 Suppl 8):16-22. Semin Oncol. 1995. PMID: 7543699 Clinical Trial.

10

Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent cultures.

Pizao PE, Peters GJ, Van Ark-Otte J, Smets LA, Smitskamp-Wilms E, Winograd B, Pinedo HM, Giaccone G. Pizao PE, et al. Among authors: winograd b. Eur J Cancer. 1993;29A(11):1566-73. doi: 10.1016/0959-8049(93)90296-r. Eur J Cancer. 1993. PMID: 8217364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters